Raymond Stevens, Structure Therapeutics CEO, joins ‘Fast Money’ to talk its oral GLP-1 offerings.
Source link
Trending
- Buffett denies social media rumors after Trump shares wild claim that investor backs president crashing market
- China announced retaliation so quickly to purposely damage U.S. stock market, says Evercore ISI
- Stocks making the biggest moves midday: PLTR, CAT, AAPL JPM
- Bitcoin rises slightly, holding at $83,000 as global trade war deepens stock market slide
- Haters guide to the Final Fo— nah, scrap that. Duke leaves no room to hate anything else
- Energy secretary’s former firm plummets after Trump tariff escalation
- Watch Fed Chair Jerome Powell speak live on interest rates and tariffs
- Small investor still believes in Trump. What they were buying during Thursday’s rout
Structure CEO on the competitive landscape for oral GLP-1 drugs
